Use of relaxin to increase arterial compliance

Details for Australian Patent Application No. 2005223694 (hide)

Owner University of Pittsburgh - of the Commonwealth System of Higher Education

Inventors Shroff, Sanjeev G.; Conrad, Kirk P.

Agent Wrays

Pub. Number AU-B-2005223694

PCT Pub. Number WO2005/089489

Priority 60/554,716 19.03.04 US

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 28 April 2011

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61B 5/00 (2006.01) Measuring for diagnostic purposes

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089489 Priority application(s): WO2005/089489

24 April 2008 Alteration of Name

  The name of the applicant has been altered to Corthera, Inc.

10 June 2010 Assignment before Grant

  Corthera, Inc. The application has been assigned to University of Pittsburgh

12 August 2010 Alteration of Name

  The name of the applicant has been altered to University of Pittsburgh - of the Commonwealth System of Higher Education

28 April 2011 Application Accepted

  Published as AU-B-2005223694

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223714-Cycle suspension assembly

2005223691-Methods for treating alcoholism